STOLFI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 20.881
AS - Asia 3.014
EU - Europa 2.433
SA - Sud America 407
AF - Africa 45
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.791
Nazione #
US - Stati Uniti d'America 20.762
SG - Singapore 1.483
CN - Cina 556
IT - Italia 507
RU - Federazione Russa 374
BR - Brasile 340
DE - Germania 309
HK - Hong Kong 271
VN - Vietnam 236
UA - Ucraina 231
IE - Irlanda 226
GB - Regno Unito 163
SE - Svezia 147
FR - Francia 146
BD - Bangladesh 141
FI - Finlandia 133
JP - Giappone 83
KR - Corea 61
CA - Canada 60
PL - Polonia 54
IN - India 47
MX - Messico 32
ID - Indonesia 25
AT - Austria 24
NL - Olanda 24
AR - Argentina 23
IQ - Iraq 21
ES - Italia 19
BE - Belgio 18
ZA - Sudafrica 18
TR - Turchia 16
LT - Lituania 12
CO - Colombia 11
EC - Ecuador 10
CL - Cile 9
AU - Australia 8
PH - Filippine 8
RO - Romania 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
TN - Tunisia 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
PY - Paraguay 6
UZ - Uzbekistan 6
GR - Grecia 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
MA - Marocco 5
PK - Pakistan 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MY - Malesia 4
NP - Nepal 4
VE - Venezuela 4
AL - Albania 3
DM - Dominica 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
LB - Libano 2
MT - Malta 2
PE - Perù 2
SV - El Salvador 2
TW - Taiwan 2
BG - Bulgaria 1
BH - Bahrain 1
BT - Bhutan 1
GI - Gibilterra 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
VG - Isole Vergini Britanniche 1
Totale 26.791
Città #
Woodbridge 5.208
Wilmington 4.610
Houston 4.454
Singapore 911
Fairfield 808
Ashburn 592
Ann Arbor 464
Chandler 431
San Jose 405
Seattle 320
Cambridge 279
Hong Kong 262
Beijing 218
Jacksonville 208
Council Bluffs 206
Dublin 204
Rome 167
Medford 164
Santa Clara 161
New York 155
Dearborn 128
The Dalles 123
Los Angeles 100
Lawrence 72
Buffalo 71
Hanoi 70
Tokyo 69
Helsinki 68
Ho Chi Minh City 57
Moscow 53
Lauterbourg 52
San Diego 45
Chicago 44
Dallas 42
Monte Vista 38
Milan 37
London 36
Kraków 34
Zhengzhou 32
São Paulo 31
Munich 30
Menlo Park 28
Mülheim 27
North Charleston 25
Orem 25
Boardman 23
Redondo Beach 23
Indianapolis 21
Chennai 19
Atlanta 18
Brussels 18
Jakarta 18
Nuremberg 18
Toronto 17
North Bergen 16
Seoul 16
Warsaw 16
Lappeenranta 15
Boston 14
Johannesburg 14
Montreal 14
Redwood City 14
Belo Horizonte 12
Brooklyn 12
Denver 12
Mountain View 12
Naples 12
Phoenix 12
Shanghai 12
Manchester 11
Norwalk 11
Palo Alto 11
Rio de Janeiro 11
San Francisco 11
Vienna 11
Colorado Springs 10
Salt Lake City 10
Da Nang 9
Draper 9
Frankfurt am Main 9
Haiphong 9
Nanjing 9
Verona 9
Bologna 8
Chengdu 8
Curitiba 8
Kilburn 8
Mexico City 8
San Mateo 8
Turin 8
Baghdad 7
Charlotte 7
Dhaka 7
Guangzhou 7
Hangzhou 7
Newark 7
Querétaro 7
Saint Petersburg 7
Stockholm 7
Sydney 7
Totale 22.208
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 582
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 565
Regulation of gut inflammation and Th17 cell response by interleukin-21 514
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 510
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 498
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 489
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 488
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 487
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 481
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 480
The dual role of Smad7 in the control of cancer growth and metastasis 477
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 475
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 473
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery 472
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 471
Colorectal cancer chemoprevention by mesalazine and its derivatives 468
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 464
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 463
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 463
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 462
Autocrine regulation of IL-21 production in human T lymphocytes 461
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 461
Collagen matrix injection combined with flap repair for complex anal fistula 458
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 452
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 452
The dual role of inflammation in colon carcinogenesis 447
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 441
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 439
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 437
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 437
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 436
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 436
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 432
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 417
Role of TH17 cytokines in the control of colorectal cancer 416
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 411
Molecular basis of the potential of mesalazine to prevent colorectal cancer 407
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 407
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer 402
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 392
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 385
Smad7 positively regulates keratinocyte proliferation in psoriasis 384
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 383
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 375
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 375
Interleukin-21 in cancer immunotherapy: Friend or foe? 347
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 339
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 316
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 265
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 255
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 232
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 228
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 224
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 211
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 196
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 189
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 184
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 154
Molecular targets of mesalazine in colorectal cancer 152
Association between celiac disease and cancer 152
Follistatin-like protein 1 sustains colon cancer cell growth and survival 151
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 145
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 140
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 139
Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system 131
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 129
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 108
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 106
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 104
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 104
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures 103
Role of interleukin-34 in cancer 102
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis 101
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 99
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 98
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 83
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut 81
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 81
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 73
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 72
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 69
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 69
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? 69
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 69
TRAIL-Sensitizing Effects of Flavonoids in Cancer 67
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 65
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 60
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 59
Impact of food additives on gut homeostasis 59
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut 56
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 54
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 54
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 53
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 51
Editorial for the Special Issue “Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0” 48
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 44
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy” 43
High Smad7 marks inflammation in patients with chronic pouchitis 39
Special Issue “Drug Treatments for Inflammatory Bowel Diseases” 35
Editorial for the Special Issue “Latest Review Papers in Molecular Oncology 2023” 34
Totale 27.016
Categoria #
all - tutte 71.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 0 59
2021/2022841 41 94 55 19 28 58 57 28 90 73 68 230
2022/20231.077 97 101 26 133 113 211 91 83 106 28 63 25
2023/2024423 50 17 24 13 42 109 21 80 4 4 2 57
2024/20252.343 71 538 305 179 50 204 137 88 250 257 169 95
2025/20264.524 297 161 412 355 409 165 492 539 538 456 441 259
Totale 27.232